A major study by the European Society of Cardiology links chronic noise exposure to an increased risk of heart attacks, particularly in men and women under 70. The study found that general environmental noise increased risk by nearly 50% for men and three-fold for women, while workplace noise levels affected men's risk but not women's.
An international study found that 21% of coronary patients continued to smoke, with younger patients and those with angina less likely to quit. The survey highlights the need for more effective smoking cessation programs, particularly among younger patients and those with lower education levels.
The European Society of Cardiology emphasizes the importance of healthy weight and exercise in preventing heart disease. Studies show that moderate physical activity can reduce the risk of cardiovascular events, while a balanced diet and weight management can also help mitigate the impact of existing heart conditions.
The study reported a 10.6% rate of stent-related MACE for the control Tecnic group, while the Janus group had a 6.4% rate, with a significant reduction in TLR, and no stent thrombosis occurred
The ELISA II trial found that triple antiplatelet (AP) therapy reduced enzymatic infarct size and improved epicardial coronary artery flow in patients with non-ST segment elevation acute coronary syndrome (NSTE ACS). Triple AP therapy also showed a trend towards better event-free survival at 96 hours and 30 days after randomization.
The STEEPLE study examines the safety and efficacy of enoxaparin in percutaneous coronary intervention patients, comparing it to UFH regimens. The results confirm earlier findings that enoxaparin is simple and effective, with minimal bleeding risk, and suggest its use as a standard treatment option.
The BASKET trial compares the costs and outcomes of drug-eluting stents (DES) and bare-metal stents (BMS) in 826 patients with PCI. The study aims to identify patient subgroups where DES are cost-effective, potentially impacting daily practice and preferences.
The SIRIUS II clinical trial demonstrated dose-dependent favorable hemodynamic effects and improvements in cardiac output and dyspnea score in patients with acute decompensated congestive heart failure (ADHF). Ularitide was well-tolerated, preserving kidney function during treatment.
The European Society of Cardiology reports a growing problem of child obesity in Europe, with overweight and overt obesity affecting nearly all countries. Scientific evidence shows that this early onset is linked to increased risk factors such as high blood pressure, insulin resistance, and metabolic syndrome.
A study of 3779 patients found women were 20% less likely to undergo an exercise test or angiography due to suspected coronary obstruction. Despite proven coronary disease, women received less aggressive treatment and were twice as likely to die or suffer a heart attack compared to men.
The Cardiac Insufficiency BIsoprolol Study III suggests starting patients on bisoprolol may reduce the risk of death, especially in the first year of treatment. The study found no significant differences in efficacy or tolerability between bisoprolol and ACE inhibitor initiation strategies.
The updated guidelines focus on prolonging life, reducing morbidity, and improving quality of life for patients with chronic heart failure. New neurohormonal antagonists, ACE-inhibitors, beta-blockers, and diuretics are key components of therapy.
The PREAMI study found that perindopril significantly reduces the risk of death, hospitalization for heart failure, and cardiac remodelling in elderly patients after acute myocardial infarction. Perindopril reduced these outcomes by 59% and cardiac remodelling by 64%, with consistent benefits across predefined subgroups.
Endovascular stent grafting successfully treats abdominal and thoracic aneurysms and type B aortic dissections. The procedure has been shown to reduce mortality rates compared to surgery in certain cases.
The study found a strong social gradient in metabolic syndrome, with individuals from lower socio-economic positions having a higher risk of the condition. Despite healthier lifestyles among those with higher education levels, the risk was still significantly lower for those with higher education.
Increased physical activity reduces coronary heart disease and cardiac mortality rates by 30-40% compared to inactive individuals. Exercise training also improves endothelial function, reducing atherosclerosis and plaque formation, and can even extend life expectancy in patients with stable coronary artery disease.
A European multi-centre study found that eating fish oil did little to reduce the risk of heart rhythm problems, cardiac arrest or arrhythmia in patients with an increased risk. The Study on Omega-3 Fatty acids and ventricular Arrhythmia (SOFA) investigated the effect of taking fish oil capsules on life-threatening cardiac arrhythmia i...
A new European consensus definition of the metabolic syndrome (MetS) reveals a high prevalence, with 38% of men and 36% of women affected. The MetS is associated with increased cardiovascular mortality rates, particularly in diabetic women, highlighting gender-specific risk factors.
A telemonitoring system tracks patients' vital parameters at home, enabling early detection of hemodynamic imbalance and prompt intervention. The study found improved health outcomes and reduced hospital re-admissions in patients with chronic heart failure.
The study found that adolescents and young adults involved in competitive sports had a two and a half times higher risk of sudden death. ECG screening identified vulnerable young people, reducing sports-related sudden death from hypertrophic cardiomyopathy.
A study of Euro Heart Survey data reveals significant gender disparities in the diagnosis, treatment, and outcome of patients with heart failure and coronary artery disease. Women tend to be older, have more comorbidities, and are less likely to receive certain treatments.
The ESSENTIAL trial found that low-dose oral enoximone therapy improved exercise capacity and reduced hospitalization rates in patients with advanced heart failure. However, the study also showed no significant difference in mortality rates between the enoximone and placebo groups.
The EuroAction project demonstrates a significant reduction in cardiovascular disease (CVD) risk factors through a family-based, behavioural approach. Patients and partners achieved improvements in lifestyle, cardiovascular risk factors, and medication use, including increased physical activity and healthier diets.
A study monitored 2640 competitive athletes with arrhythmias, finding that 62 reported cardiac arrests and 38 were resuscitated. Illicit drugs, particularly anabolic steroids, increase the risk of lethal arrhythmias in athletes. Monitoring and treatment are crucial for young athletes and elite competitors.
The IMAGINE study found that adding an ACE inhibitor within seven days of CABG surgery does not improve current optimal treatment for low-risk patients without a clear indication. The trial, led by Canadian and international researchers, aimed to investigate the benefits of early post-surgical intervention with quinapril.
Acute heart failure is a significant concern, affecting approximately 30% of acute coronary syndrome patients, with female patients showing higher prevalence rates. Hospitalizations for heart failure are comparable to myocardial infarctions, with high mortality rates during hospitalization and follow-up.
The article highlights the significant disparity in cardiovascular disease (CVD) knowledge and treatment among European women. Women are more likely to develop CVD ten years after men, but it is also more lethal when it occurs suddenly, such as one year after a heart attack.
Resynchronization therapy has shown efficacy in a specific subgroup of patients with heart failure, improving hemodynamic benefits, exercise tolerance, quality of life, and mortality. However, controversies surround its role in narrow QRS, atrial fibrillation, or right ventricular failure, as well as patient selection, due to high costs.
Transcatheter occlusion of PFO and left atrial appendage eliminates key sources of cardiac embolism, preventing strokes. Alternative to blood thinning therapy, this procedure is safe and effective in preventing stroke, with a lower recurrence rate compared to standard treatment.
The metabolic syndrome is frequently present in middle-aged subjects, coinciding with adverse cardiovascular changes, including inflammation, thickening of the heart, and atherosclerosis. Every additional component of MS increases the likelihood of cardiovascular damage.
The Cribier-Edwards Percutaneous valve offers a less invasive solution for patients with fibro-calcific native aortic valves, reducing mortality rates associated with untreated disease. Recent developments include custom retrograde delivery systems and larger valve sizes, improving procedure success rates.
Researchers from Norway found that treating patients with high doses of B vitamins after a heart attack does not prevent recurrent heart disease or stroke. In fact, high doses of B vitamins may increase the risk of cardiovascular disease, particularly among those with impaired renal function.
A new study demonstrates that improved patient selection methods lead to significantly better therapy outcomes for patients with suspected neurally-mediated syncope. The study used implantable loop recorders and found a lower recurrence rate in patients who received pacemaker therapy.
A new study has shown that fondaparinux, a synthetic drug, is as effective as traditional therapy in preventing heart attacks and ischemia while reducing major bleeding risks. Patients with acute coronary syndromes who received fondaparinux had lower mortality rates at one month and six months compared to those receiving enoxaparin.
Regular aerobic exercise training is safe and beneficial for cardiac patients, even those with reduced left ventricular function. Appropriate screening and controlled exercise intensity are crucial to minimize risk. Athletes with coronary artery disease can participate in low-intensity competitive sports under supervision.
The study evaluates the feasibility and effectiveness of continuous telemonitoring of multiple disease-relevant parameters in patients with chronic heart failure. The results show that treatment can be adjusted before deterioration, leading to a gain in feeling of security and reduced hospital re-admissions.
A recent international survey found that nearly 90% of Europeans are aware of heart failure, but only 3% can identify its symptoms. The study also revealed major misconceptions about the condition, including the notion that it is a normal consequence of aging or that modern drugs cannot prevent its development.
Key findings highlight the importance of including women in clinical trials due to differences in response to drug therapy, such as higher levels of adverse reactions and varying mortality rates. This lack of data affects treatment strategies, with many drugs prescribed to women adapted from studies conducted mainly in men.
The European Commission's Heart Health Conference aims to promote cardiovascular disease (CVD) prevention measures across Europe. The conference concluded with key actions for member states and the EC to implement to improve cardiovascular health in Europe, emphasizing the need for a long-term approach through public health strategies.
Research by Dr Amy Ferketich and Dr Philip Binkley found that men and women with heart disease in the US experience high levels of psychological distress, with only a third seeking mental health support. The study analyzed data from over 17,000 individuals with different forms of heart disease, highlighting the need for clinicians to c...
Heavy smoking is associated with a four-fold increase in major cardiovascular events, emphasizing the need for enhanced policies and individual support. The European Society of Cardiology advocates for smoke-free environments and access to quitting resources.
The ESC has released new chronic heart failure guidelines featuring practical recommendations for diagnosis, assessment, and treatment of CHF. The guidelines highlight significant developments in CCF management, including the use of natriuretic peptides and device-based therapies.
A Dutch study found that non-cardiac drugs affecting heart electrical activity increase sudden cardiac death risk by three times. Anti-psychotics and GI medications were most closely linked to this increased risk.
A large European study found that only 60% of patients with heart failure were treated according to the ESC guidelines for the five most commonly used cardiac drugs. Adherence to treatment guidelines was independently correlated with patient outcomes, including hospitalization rates and time to readmission.
A recent study found that only three out of 21 streptokinase preparations met the minimum requirements of the European Pharmacopoeia, highlighting the need for stricter calibration and monitoring. The lack of reliable testing methods and inadequate post-marketing control allow substandard drugs to enter the market.
The new guidelines emphasize the importance of timely thrombolysis and PCI, with a focus on reducing delays in treatment. They also highlight the benefits of primary PCI over thrombolysis in certain situations.
The European Society of Cardiology has launched a new initiative called Women at Heart to improve the handling of women with cardiovascular disease. The initiative aims to highlight the growing burden and under-appreciation of women's heart disease, and promote better understanding and treatment among medical professionals.
A European Society of Cardiology consensus report recommends regular physical examination, detailed medical history investigation, and a 12-lead ECG for all young athletes involved in organized sport. This could potentially cut sports-related cardiac deaths by 50%-70% if implemented across Europe.
Bone marrow derived stem cells can give rise to heart muscle cells through transdifferentiation, a process that has sparked debate and potential applications in heart repair and transplantation. The concept challenges traditional dogma of tissue specific stem cell differentiation in adults.
A new study found that eccentric muscle training, such as hiking downhill, improves glucose tolerance by 25.0%, compared to 9.4% with concentric training, like hiking uphill. This research provides insight into the specific metabolic effects of different types of exercise on glucose metabolism in humans.